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AIM OF THE STUDY
The study aims to compare the effectiveness of oral low dose combination of Midazolam 0.25 
mg/kg and Ketamine 3 mg/kg against conventional doses of Midazolam 0.5 mg/kg  orally or Ketamine 
6 mg/kg orally alone.
The study is intended to test whether there is any synergism in this combination and additional 
advantages in terms of time of onset, sedation, anxiety scores at parental separation, hemodynamic 
stability, recovery and postoperative side effects.
Introduction
Preparing the pediatric patients for surgery can be a complex  process because of many 
individuals and factors involved.  A hospitalized child has fear of separation, fear of pain, physical 
trauma and fear of stranger or unknown.  The child can predict and anticipate pain on the basis of past 
experiences but cannot reason out or accept explanations from doctors and nurses.  The child can’t 
communicate the fear and anxiety but can only cry.  The fear can be so severe that it can manifest as 
various forms of regressive behaviours after hospitalization.
Anxiety is created by the fear of the unknown and the uncertainity of what constitutes 
acceptable or appropriate behaviour in the hospital environment in elder children.
Hence traumatic experiences in the tender minds of children can be effectively 
prevented by a very good premedication.  Parenteral premedication aggravates the fear and anxiety of 
pediatric patients.  Oral premedication is an easily acceptable alternate route of achieving a calm, 
sedated child for smooth induction of anaesthesia.  Oral premedication has good patient compliance 
and is very easy to administer.  A  calm child entering the operation theatre also provides parental 
satisfaction removing  fears from their minds too.
Oral Ketamine and Oral Midazolam have been tried for the last twenty years as good 
premedicants with varying results.  A combination of low dose Midazolam and Ketamine has been 
used in this study to find out whether there is advantage in terms of minimal  side effects, sedation 
onset when compared to individual drugs.
PREMEDICATION IN PEDIATRICS
Premedicaton in pediatric age group is necessary for smooth induction of anaestheisa.
ADVANTAGES OF AN IDEAL ATRAUMATIC PREMEDICATION
An ideal atraumatic premedicant can decrease separation anxiety, improve induction by mask 
acceptance, minimizing emotional trauma. Decreased occurrence of negative behavioural problems 
post surgery has been observed.  Kain , etal1 have shown that premedication with Midazolam decreases 
the incidence of negative behavioural problems after surgery.  They have also shown that increased 
preoperative anxiety can increase the incidence of postoperative negative behavioral problems.
ROUTES OF ADMINISTRATION OF PREMEDICATON
Premedication can be administered by various routes – nasal, oral, rectal, sublingual, parenteral 
– intramuscular and  intravenous.  Every route of administration has its own advantages and 
disadvantages.  A successful premedication can be individualized according to the underlying medical 
conditions, length of the surgery, the desired induction of anaesthesia, and the psychological makeup of 
the child and the family.  Although most of the routes are effective and reliable each has its own 
drawbacks.
Intramuscular Route is painful to administer, threatening to the child, can cause  sterile 
abscess and is a major adverse experience – the child remembers the shot received.
Rectal medications make the patient feel uncomfortable cause defecation, occasionally burn. 
Irregular absorption of the drug is observed .  Some degree of delayed  respiratory depression is 
present.
Nasal medications can be irritating, though absorption is rapid.  The drug may traverse directly 
into the central nervous system through the cribriform plate along the olfactory nerves.  Only 
preservative free drugs can be given because of the potential for neurotoxicity.  The drugs given in the 
nasal route are not completely retained in nasal mucosa  especially in children but drip down into the 
pharyux and may be spit out by the children.
Intra venous route – need for intravenous  cannulation – to be made painless by use of 
EMLA..
Oral or sublingual route do not hurt but may have a slow onset or be spit out.
Hence Drug taste and patient cooperation are the main determinants of success.
ORAL PREMEDICATION IN PEDIATRICS.
Oral premedication is atraumatic, easy to administer and has good patient compliance.  Various 
drugs have been tried for pediatric premedication.  Before the advent of pediatric anaesthesia, sugar 
dipped pacifiers or whiskey nipples, were used in conjunctions with restraints for surgical operations 
such as pyloromyotomy in neonates.
DRUGS USED FOR ORAL PREMEDICATION
Earlier oral chloral hydrate 20 – 75 mg/kg was used.   Peak effect reached in 1 hour in 
sedating the child.  
Oral Midazolam 0.25 mg/kg - 0.5 mg/kg with onset within 20 minutes provides satisfactory 
sedation with minimal to no delay in recovery even for brief procedures.  Main disadvantage of oral 
Midazolam is its bitter taste which is counteracted by combining with chocolate syrup or additives.
Oral Ketamine 3 – 10 mg/kg has been successfully used as a premedicant and results in a calm 
child within 15 minutes after premedication.  Increasing doses increases side effects such as emesis.
Oral Ketamine 3 – 6 mg/kg with oral Midazolam 0.25 mg/kg –0.5 mg/kg has been found to 
provide profound depth of anaesthesia.
Fentanyl ( 10mcg/kg) Oral Transmucosal fentanyl Citrate provides an unique method of 
administration which takes advantage of rich absorption of drugs through the oral mucosa.  But the 
disadvantages includes high costs and not available freely.
PHARMACOLOGY OF MIDAZOLAM
Midazolam, an imidazobenzodiazepine derivative is utilized as a premedicant, sedative and an 
aneasthetic induction agent.  Synthesised in 1976 by Fryer and Walser, its unique structure confers a 
number of physicochemical properties that distinguish it from other benzodiazepine in terms of 
pharmacologic characteristics.
Midazolam ( molecular weight 362) has a fused imidazole ring that is different from classic 
benzodiazepines.  The imidazole ring accounts for the basicity , stability of an aqueous solution and 
rapid metabolism.   pKa of Midazolam is 6.15 which permits preparation of salts which are water 
soluble.  At physiologic pH, Midazolam becomes highly lipophilic and is one of the most lipid soluble 
benzodiazepines.  The high lipophilicity accounts for its rapid absorption from gastro intestinal tract 
and  rapid entry into brain tissue after intra venous administration.
PHARMACODYNAMICS
Midazolam has anxiolytic, hypnotic, anticonvulsant, muscle relaxant and antegrade amnesic 
effects. 
Mechanism: 
Facilitates inhibitory actions of GABA and mimics inhibitory actions of glycine .
EFFECTS ON CNS.
CEREBRAL EFFECTS – HYPOXIC BRAIN PROTECTION
Midazolam is a dose related manner, reduces cerebral metabolic rate for oxygen ( CMRO2) and 
cerebral blood flow and is helpful in cerebral protection against ischemic insult.
EFFECTS ON RESPIRATORY SYSTEM
Midazolam produces some respiratory depression decreasing the ventilatory response to 
carbondioxide.  Apnea is related to the dose and also speed of injection.  Apnea is more likely to occur 
in patients premedicated with opiods and receiving Midazolam.
EFFECTS ON CARDIO VASCULAR SYSTEM 
In normal humans, significant  reduction in systolic (5%) and diastolic (10%) blood pressure 
and increase in heart rate (18%) occurs.  Cardiac index and left ventricular filling pressures are 
maintained  but systemic vascular resistance may decrease 15-33%
METABOLISM AND PHARMACOKINETICS.
Metabolism involves hydroxylation of hepatic microsomal oxidative mechanism.  The 
metabolites are excreted in the urine in the form of glucoronide conjugates.  The elimination half life is 
1.5 – 3.5 hours.
The high lipophilicity of Midazolam, coupled with its very high metabolic clearance and 
rapid rate of elimination cause it to have a short duration of activity.  
After Oral administration, Midazolam is rapidly absorbed from gastro intestinal 
tract.   Peak concentrations are  achieved within one hour  of  ingestion.   Because of 
extensive  first  pass  metabolism  only  40-50  percent  of  oral  dose  reaches  systemic 
circulation.  Hence Oral dose should be twice higher than intravenous dose to achieve 
comparable clinical effects.  
USES OF MIDAZOLAM DOSAGE ROUTE         
1. Induction of Anaesthesia 0.15.0.40mg/kg. iv
2.  Maintenance Titration iv
3.  Premedication 0.07 – 0.10mg/kg im
0.25 – 0.5mg/kg Oral
4.  iv sedation 0.05 – 0.15 mg/kg  iv
Midazolam is preferred in maintenance of anaesthesia as it confers more amnesia, 
has fewer emergence complications. Midazolam is well suited for premedication as it 
has sedative and anxiolytic properties.   Performance on tests of mental function returns 
to normal  four hours after administration of Midazolam.
harmacology of Ketamine
Ketamine is a sedative, synthetic, nonbarbiturate compound which acts as CNS 
depressant producing rapid acting dissociative effect.  It is a phencyclidine derivative 
described by Prof. Edward Domino as a potent psychedelic drug in 1970.  
Ketamine is available as white crystalline powder which is diluted in water to 
yield a colorless solution containing 10/50/100mg/ml of racemic ketamine hyrochloride. 
Ketamine exists as – racemic  mixture of R and S optical isomers with ‘S’ isomer having 
a potency 3-4 times that of ‘R’ isomer.  
Ketamine produces dissociative  anaesthesia, which is a trance like state in which 
the  individual  separates  perception  from  sensation  –  a  combination  of  profound 
analgesia and superficial sleep.  
Mechanism of action
Ketamine is a noncompetitive antagonist of NMDA receptor Ca++ channel pore 
and also inhibits  NMDA receptor activity by interaction with phyencyclidine binding 
site.  It may also modulate  opiod and muscarinic receptor activity. 
routes of administration / doses
The intramuscular dose of Ketamine is 10mg/kg .  Onset of action is 2 - 8minutes and the 
duration of action is 10 - 20 minutes.  The intravascular drug dosage is 1.5 - 2 mg/kg administrated 
over a period of 60 seconds.  Onset of action is within 30seconds and duration of action is 5-10 
minutes.  Infusion dose is 50mcg/kg/min.  Oral dose of Ketamine is 3-10mg/kg .  Ketamine can be 
given intrathecal and extradural route. 
effects
Cardio Vascular System - Ketamine causes tachycardia, an increase in  blood 
pressure, central venous pressure, cardiac output secondary to increase in sympathetic 
tone.  Baroreceptor function is well maintained and dysrhythmias are uncommon.
 
Respiratory  System  –  Ketamine  causes  mild  stimulation  of  respiration  with 
relative preservation of airway reflexes.  Bronchodilation is the feature of action of the 
drug.
   
Central Nervous System – The state of dissociative  anaesthesia is produced by 
Ketamine.   The cerebral  bloodflow,  cerebral  metabolic  rate,  intraocular  pressure  are 
increased.   Amnesia occurs.  Visceral pain is poorly obtunded by Ketamine.  The EEG 
demonstrates dominant theta activity and loss of alpha activity.  
Gastro  Intestinal  Tract  –  Postoperative  nausea  and  vomiting  are  common. 
Salivation is increased and no effect is observed in gastrointestinal motility. 
 
Metabolic – The level of circulating  adrenaline and noradrenaline are increased. 
TOXICITY
Transient  rashes  occur  in  15% of  patients.    Emergence  delirium,  unpleasant 
dreams, hallucinations are notable side effects.
Pharmacokinetics
Absorption – Ketamine is well absorbed after oral or intramuscular route.   Oral 
bioavailability is 20%.
Distribution  –  Ketamine  is  20-50%protein  bound.    Volume of  distribution  is 
3l/kg.  The distribution half life is 11min.  Recovery is thus due to redistribution from 
brain to peripheral tissues.  
Metabolism
Ketamine is converted in the liver by Ndemethylation and hydroxylation  of the 
cyclohexyl amine ring.  Some of the metabolites are pharmacologically active.  
excretion
The  conjugated  metabolites  are  excreted  in  the  urine.   The  clearance  is 
17ml/kg/min. and elimination half life is 2.5 hours.  
The unpleasant dreams produced by Ketamine is reduced           by premedication 
with  a   benzodiazepine.   Ketamine  reduces  the  requirement  for  inotropic  support  is 
septic patients.  
USES
1. Ketamine is very useful as a premedicant and can be given orally, 
intramuscularly or intravenously before induction of anaesthesia.
2. Ketamine  is  used  for  induction  of  anaesthesia  in  poor  risk  patients  with 
hypotension or asthma. It is the induction agent of choice in fallot’s tetrology.  
3. As a sole agent for short procedures like burns dressings and radiological and 
radiotherapy procedures is children.  
4. As an agent for mass casualities in the field. 
5. For pain relief in patients with chronic pain.  
6. For analgesia both postoperatively and in patients receiving intensive care.  
REVIEW OF LITERATURE
Midazolam: 
Midazolam is currently the most popular premedicant in children.  Several recent studies have 
focused attention in pH  and composition when given in oral form.  Commercial preparation of 
Midazolam was studied in a multicentered study by Cote’etal and was found to be effective in doses as 
low as 0.25 mg/kg.  They also found that the Oral bio availability of the agent was 36% higher than 
anticipated and the onset time was 10-20 minutes in a majority of the patients. 
Brosius and Bannister14 measured the sedation scores (observer assessment of 
alertness/sedation) OAA/S as well as plasma levels of Midazolam in 50 healthy children 2-10 years old 
undergoing minor surgical procedures.  The children received either commercially available 
Midazolam syrup (pH 2.4 to 3.6) or IV  Midazolam mixed in syrpalta syrup (pH 4.5 to 5).  They found 
lower sedation scores and higher plasma concentrations in patients receiving  syrpalta syrup with 
Midazolam.  The higher pH increases the oral absorption that decreases the first pass metabolism.  
Several studies examining the long term effects of Midazolam prove lower incidence of 
negative postoperative behaviour in children (Kain et al)17. 
Disadvantages of Larger doses of Midazolam 
Viita nen et al and  Valley et al demonstrated that recovery after sevoflurane anaesthesia was 
prolonged with larger doses of oral Midazolam.  
On the other hand Shimonaka and colleagues found that they did not achieve adequate 
sedation with 0.5mg/kg or 1mg/kg of oral Midazolam in infants and children undergoing 
cardiovascular surgery. Their patients required 1.5mg/kg to achieve adequate sedation .
KETAMINE
Doses of 3 to 6 mg/kg per oral is effective as sedative and anxiolytic.  However side effects like 
dysphoria, hallucinations were observed at higher doses by Funk et al 16. 
Recent studies have renewed interest in oral Ketamine, particularly when combined with oral 
Midazolam.  Trabold et al19 found that adding 3mg/kg of oral Ketamine to 0.5mg/kg of Oral 
Midazolam improved sedation at induction and did not prolong emergence or discharge from PACU. 
Funk et al16 compared oral Ketamine 3mg/kg added to oral Midazolam 0.5mg/kg with oral 
Ketamine 6mg/kg alone or oral Midazolam 0.5mg/kg alone.  
They found separation, anxiolysis better with the combination of Ketamine and Midazolam than 
with either drug alone. 
They surveyed the parents 1 to 7 days later and found the higher incidence of emesis or vertigo 
in patients who received only Ketamine.  There were no occurrences of negative behaviour in any of 
the Groups. 
The clinical practice guidelines for emergency department Ketamine dissociative sedation in 
children by Steve M.Greene and Krauss9 states that “ Preliminary evidence suggests that concurrent 
anticholinergics are unnecessary with Ketamine”.  Concurrent anticholinergics have been traditionally 
administered with the intent of minimizing Ketamine associated hypersalivation although recent 
evidences suggest that this recommendation has been overstated. 
J. Cravero, G. Blike M.D., et al Dartmouth Hitchcock Medical Center in their pediatic 
sedation course have stated that oral secretions are mildly increased with oral Ketamine, athough 
administration of an antisialogogue is rarely required.  
Comparison between Ketamine and Midazolam as oral premedicants in children by 
Dr.Suranjith Debnath et al6 (Indian journal of Anaesthesia 2003, 47(1), 45-47) concludes that oral 
premedication with Ketamine 6mg/kg is better than Midazolam 0.5mg/kg in terms of better sedation 
scores, anxiolysis and smooth postoperative recovery. 
Recommendation for using Ketamine as a sedative or analgesic or anesthetic during the peri-
operative period by Paul F white8 in ‘Text of Intravenous Anesthesia” advices concurrent 
administration of a Benzodiazepine orally one hour before surgery and an Anti-sialogogue 5-10 
minutes before induction. 
In a study Comparing low dose versus high dose of Oral Midazolam and Oral Ketamine for pre-
anesthetic medication in pediatric patients [Canadian journal of Anesthesia 50:A27 (2003)] has proved 
the onset of pre-operative sedation and recovery by Aldrete score was significantly early in the low 
dose group – Oral Ketamine     3mg/kg and Oral Midazolam 0.25mg/kg.  Apart from delayed recovery, 
the high dose group – oral Ketamine 6 mg/kg and oral Midazolam 0.50mg/kg had higher incidence of 
salivation. 
Epstein30 anecdotally describes no difficulty with administration of Ketamine without an 
anticholinergic to approximately 1100 children. [Ref. Epstien FB, Ketamine Dissociative Sedation in 
Pediatric Emergency Medical Practice, American Journal of Emergency Medicine 1993, 11:180-182].
Materials and methods
Seventy five children aged between 1 and 12 years, ASA grade I, II undergoing elective surgery 
were included in the study. Consent obtained from their parents. The Hospital Ethical Committee 
approval obtained.  The children were randomly allocated into 3 groups of 25 each. Oral atropine 
0.02mg/kg was administered to all the children one hour before surgery.  
Drugs used – Ketamine (50mg/mlvial), Midazolam (1mg/mlvial)
Group KM
Children  of  the  group  were  given  orally  Ketamine  in  a  dose  of  3mg/kg  and 
Midazolam in a dose of  0.25mg/kg after mixing with honey to avoid the bitter taste of 
the drugs, 30 minutes before surgery. 
group k
Children  of the group were given Ketamine in a dose of 6mg/kg Orally mixed 
with honey, 30 minutes before surgery.  
group m
Children  of the group were given Midazolam in a dose of 0.5mg/kg Orally mixed 
with honey, 30 minutes before surgery. 
All  the  children  were  constantly  monitored.    The  heart  rate,  Blood pressure, 
Oxygen Saturation were recorded every 10 minutes upto 30 minutes before induction. 
Children were constantly  observed for  changes  in  the mood,  behaviour,  appearance, 
onset of sedation time when sedation score was less than or equal to 3. Sedation level at 
30 minutes after premedication, anxiety level at the time of parental separation, at the 
time iv cannulation and mask acceptance was noted.  The children were observed for 
side effects like hiccough, salivation, euphoria, nausea, vomiting preoperatively.  
To assess the level of sedation, a 5 point sedation scale was used. 
 SCORE SEDATION LEVEL
1 Barely arousable (full sleep)
2 Eyes closed (light sleep)
3 Eyes open but drowsy
4 Awake
5 Agitated 
To assess the level of anxiety, a 4 point scale was followed. 
SCORE ANXIETY LEVEL
1 Calm, sleepy
2 Apprehensive but withdrawn from surroundings
3 crying
4 agitated, difficult to control
Intravenous Cannulation with appropriate  iv cannula done. In crying, agitated 
children, halothane was administered by mask to calm the children and 
Nitrousoxide – oxygen - halothane by mask used to secure iv line.   Isoyte P started 
at appropriate rate.   
Intraoperative monitoring included precordial stethoscope, pulse oximetry, ECG, 
and noninvasive Blood pressure.  
All the surgeries were proceeded under General Anaesthesia with controlled 
ventilation using Mapleson F circuit (Jackson Rees Circuit). Preoxygenation with 
100% oxygen was carried out and anaesthesia induced with injection Thiopentone 
sodium 5 mg/kg iv and injection Succinylcholine 2mg/kg iv.  Intubation done  with 
appropriate endotracheal tube.  Increased secretions during laryngoscopy and 
intubation if present were noted.  Anaesthesia was maintained with Nitrous oxide 
66% oxygen 33% and Halothane 0.5 - 1%.   Injection vecuronium 0.08 mg/kg iv 
was used as muscle relaxant.  At the end of the surgery, Injection Neostigmine 
50mcg/kg iv and injection atropine 20 mcg/kg iv were used for reversal and patient 
extubated after recovery of reflexes.
Postoperatively Oxygen saturation, continuous heart rate monitoring done and Blood pressure 
recorded every 10 min.  Recovery is assessed by Aldrete score.  Crying, Irritability, nausea vomiting, 
hallucinations and any other side effects upto 6 hours were looked for in the postoperative period.
ALDRETE SCORE
PARAMETER      OBSERVATION ALDRETE SCORE 
1. Color Pink 2
Pale or dusky 1
Cyanotic 0
2. Respiration can breathe deeply and cough 2
 shallow but adequate exchange 1
Apnea or obstruction 0
3. Circulation BP within 20% of normal 2
BP within 20-50% of normal 1
BP deviating >50% from normal 0
4. Consciousnes Awake, alert, oriented 2
Arousable, but readily drifts 
back to sleep 1
No movement 0
5. Activity Moves all extremities 2
Moves 2 extremities 1
No movement 0
Post Anaesthetic Recovery score – Ideally the patient should be discharged when the Aldrete 
score or total score across the above parameters is 10.
OBSERVATION AND RESULTS
All the seventy five children accepted the drug and no vomiting was reported after swallowing 
the drug.
1.Onset of sedation
Onset of sedation was 9.92 ± 0.64 minutes in Group KM and 15.16 ± 3.80 minutes in Group K 
and 12.08 ± 3.83 minutes in Group M. Group KM has quick onset of sedation and is found to be 
statistically significant.
Group Onset of sedation time in minutes
KM 9.92 ± 0.64
K 15.16 ± 3.8
M 12.08 ± 3.83
II. Sedation Score– 
In Group KM
60%  of  patients were barely arousable (Sedation score - 1)
40%  of  patients had their eyes closed ( Sedation score – 2)
Hence 100% of patients in Group KM attained a sedation score of < 3.
In Group K, 20% of patients had full sleep (sedation score – 1) 32% of patients had light sleep 
(score – 2), 36% of patients were drowsy (score 3) and 12% of the patients were awake.
In Group M, 20% of the patients had light sleep (score 2), 20% of the patients had their eyes 
open but were drowsy (score 3).  But 60% of the patients were awake.
Hence 100% sedation was achieved in Group KM (score < 3) 88% of patients in Group K and 
40% of patients in Group M were well sedated.  The rest remained awake.







% of pts 
Group M 
% of pts
1 60 20 0
2 40 32 20
3 0 36 20
4 0 12 60
5 0 0 0
III  Anxiolysis Score 
A. AT PARENTAL SEPARATION 
92% of the patients In Group KM were calm and sleepy and 8% were apprehensive but 
withdrawn  from surroundings.
In Group K 32% of the patients were calm and sleepy, 48% were apprehensive but withdrawn 
from surroundings and 20% were crying.
In Group M 16% of the patients were calm and sleepy, and 64% of the patients were 
apprehensive but withdrawn from surroundings and 20% of the patients were crying.
INFERENCE : Anxiolysis score was good in Group KM where 100% of the patients were 
calm at parental separation.  Only 80% of the patients in group K and group M were calm at parental 









1 92 32 16
2 8 48 64
3 0 20 20
4 0 0 0
B. AT IV CANNULATION
ANXIOLYSIS SCORE AT IV CANNULATION
In Group KM, 88% of the patients were calm, and 12% of the patients were withdrawn from 
surroundings at iv cannulation.
In Group K, 44% of the patients remained calm,36% of the patients were apprehensive but 
withdrawn from surroundings, 12% were crying and 8% were difficult to control and were 
noncooperative for iv cannulation.
In Group M, 12% of the patients remained calm, 16% were quiet withdrawn from 
surroundings, 60% were crying and 12% were difficult to control – were non co operative for iv 
cannulation.
INFERENCE :  100% of the patients in Group KM, 80% of the patients in Group K and 28% of 
patients in Group M remained calm at iv cannulation and the difference is significant. 
 None of the patient in Group KM cried at iv cannulation 12% of the patients in Group K and 









1 88 44 12
2 12 36 16
3 0 12 60
4 0 8 12
IV  Recovery Time – Measured from Aldrete Score of 10 
In Group KM,  the recovery time was 36.92 ± 5.82 min and in Group K the recovery time was 
29.0±8.72 min. and in Group M the recovery time was 18.24 ± 9.27 min and the difference is 
significant.
Group Recovery Time in minutes
K M 36.92 ± 5.82
K 29.0 ± 8.72
M 18.24 ± 9.27
SIDE EFFECTS
Preoperatively 4% of the patients in Group KM had increased salivation, 12% of the patients in 
Group K had increased salivation.





















0 0 60 Difference is 
significant
Hiccough 0 0 8 Difference is 
Not 
significant




52% of the patients cried postoperatively in Group M while none cried in the postoperative 
period in Group KM and Group K. 68% of the patients in Group M were irritable while none were 
irritable in group KM and Group K.  The difference is significant. 
16% of the patients in Group K had nausea and 8% had vomiting in Group K, while no nausea, 
vomiting was reported in Group KM and Group M postoperatively.  
12% of the patients in Group K had hallucinations while no hallucination was reported in Group 






%  of pts
Group M 
%  of pts
Statistical data
P = 0.05
Crying 0 0 52 Difference is 
significant
Irritability 0 0 68 Difference is 
significant
Nausea 0 16 0 Difference is 
significant
Vomiting 0 8 0 Difference is not 
significant
Hallucination 0 12 0 Difference is 
significant
RESULTS SUMMARIZED
The onset time and post-operative time were statistically analyzed using student’s unpaired ‘t’ 
test. 
The Sedation Scores, Anxiolysis Scores, pre-operative and post-operative side effects were analyzed 




















Sedation score < 3 
within 30 min.




100% 80% 80% Difference is 
significant
Anxiolysis score: cried 
at parental separation
0% 20% 20% Difference is not 
significant
Anxiolysis score: calm 
at IV cannulation
100% 80% 28% Difference is 
significant
Anxiolysis score: cried 
at IV cannulation
0% 12% 60% Difference is 
significant
Anxiolysis score: non-
cooperative at IV 
cannulation
0% 8% 12% Difference is not 
significant
Post –operative 











A Study involving 75 children randomly allocated into 3 groups. 
Group-KM Receiving low dose combination of Midazolam 0.25 mg/kg and Ketamine 3mg/kg orally 
mixed with honey, as pre-medication.
Group-K Receiving Ketamine 6mg/kg orally mixed with honey as pre-medication. 
Group-M Receiving Midazolam 0.5mg/kg orally mixed with honey as pre-medication.
This pre-medication was given 15-30 minutes before surgery and evaluated. 
The study proves that the combination of low dose Midazolam and Ketamine is efficacious in terms of 
providing. 
i. Rapid onset of sedation
ii. Good sedation scores < 3 within 30 minutes with minimal side effects
iii. Better Anxiolysis scores at parental separation, IV Cannulation.
iv. Haemodynamic stability
v. Less incidence of post-operative complications
vi. Smooth induction
vii. Smooth Recovery post-operatively with no emergence reactions.
This has been supported by various studies and references by Trabold et al, Funk et al, Cote et al, 
Epstein FB. 
DISCUSSION
Lin YC et al11 showed that 6mg/kg of Ketamine made better sedation and anxiolysis than 0.5 
mg/kg Midazolam. 
Feld et al8 and Alderson et al9 observed that 0.5 mg/kg of Midazolam could not produce sleep in 
children even after 30 minutes. 
The optimun dose of Midazolam as recommedded by Kothari et al12 and Jone et al17 for satisfactory 
sedation and anxiolysis is 0.75 mg/kg. 
When Oral Midazolam 0.5mg/kg alone was used as a pre-medicant, only 40% of the 
patients included in the study achieved a sedation scored < 3 and 60% of the patients were euphoric 
20% cried at parental separation, 60% cried at IV cannulation, 12% were non-cooperative.  Post-
operative crying and irritability were observed in more than 60% of the patients. 
When oral Ketamine 6mg/kg alone was used as a pre-medicant, 88% of the patients 
included in the study achieved a sedation score < 3 and 80% were calm at parental separation and IV 
cannulation. 
Although there was a 12% incidence of increased salivation, recovery was smooth except for 
occurrence of emesis (8%) proving that increasing the dosage of Ketamine is associated with increased 
dosage-related side effects [Ketamine-effects on   Human performance and behaviour, Mozayani4, 
Forensic Science Review – 14:123; 2002]
Many studies have proved that combined oral Ketamine and Oral Midazolam is better in 
terms of sedation, anxiolysis and smooth recovery. 
Addition of Midazolam to Ketamine in low doses has proved that the combination has 
synergistic effect.  The side effects of Ketamine like halluncination are nullified with Midazolam. 
Smooth recovery with stable haemodynamics is observed.  
Studies by Funk16 et al and Trabold19 et al proved that the combination of Oral Ketamine 3 
mg/kg and oral Midazolam 0.5mg/kg improved the depth of sedation and did not prolong emergence or 
discharge from PACU. 
Oral pre-medication with a combination of low-dose Ketamine 3mg/kg and oral Midazolam 
0.25mg/kg given 15-30 minutes before surgery has proved to be efficacious in terms of quicker onset 
(onset time 9.92 minutes) and better sedation score (100% sedated within    30 minutes; sedation 
score<3)
Minimal side effects were observed and incidence of salivation was less than 10% (Not 
significant). 
Hemodynamic stability was well maintained and post operative recovery was quite and smooth 
without any side effects. 
CONCLUSION
A combination of oral low dose Midazolam 0.25mg/kg and oral Ketamine 3mg/kg is found to 
be efficacious when compared to individual Midazolam 0.5mg/kg and individual Ketamine 6mg/kg in 
terms of better onset of sedation, adequate depth of sedation, anxiolysis Haemodynamic stability and 
good, smooth post-operative recovery. 
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